Pharma-Bio Serv (PBSV) Gross Profit (2010 - 2026)

Pharma-Bio Serv's Gross Profit history runs 16 years deep, the most recent figure standing at $902041.0 for Q2 2026.

• Gross Profit for Q2 2026 came in at $902041.0, up 10.18% year-over-year; the trailing twelve-month figure through Apr 2026 was $2.9 million (changed 0.04% YoY), and the FY2025 annual result was $2.9 million, up 15.66% from the prior year.
• Gross Profit came in at $902041.0 for Q2 2026 at Pharma-Bio Serv, up from $722374.0 in the prior quarter.
• In the past five years, Gross Profit ranged from a high of $1.6 million in Q3 2023 to a low of $535609.0 in Q1 2024.
• A 5-year average of $944352.4 and a median of $860383.5 in 2025 frame the typical range for Gross Profit.
• Across the five-year window, Gross Profit slumped 59.01% in 2024 and soared 43.41% in 2025, its largest moves.
• Over 5 years, Gross Profit stood at $1.1 million in 2022, then fell by 16.13% to $929805.0 in 2023, then declined by 21.86% to $726570.0 in 2024, then increased by 3.08% to $748935.0 in 2025, then advanced by 20.44% to $902041.0 in 2026.
• The last three Gross Profit figures came in at $902041.0 (Q2 2026), $722374.0 (Q1 2026), and $748935.0 (Q4 2025), per Business Quant data.